RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Andrew Taylor to Liver Neoplasms

This is a "connection" page, showing publications Andrew Taylor has written about Liver Neoplasms.
Connection Strength

0.814
  1. Sanghvi T, Boyum J, Spilseth B, Schat R, Estby H, Taylor A. MRI for hepatocellular carcinoma: a primer for magnetic resonance imaging interpretation. Abdom Radiol (NY). 2018 05; 43(5):1143-1151.
    View in: PubMed
    Score: 0.523
  2. Rostambeigi N, Taylor AJ, Golzarian J, Jensen EH, Pruett TL, Dudeja V, D'Souza D. Effect of MRI Versus MDCT on Milan Criteria Scores and Liver Transplantation Eligibility. AJR Am J Roentgenol. 2016 Apr; 206(4):726-33.
    View in: PubMed
    Score: 0.112
  3. Schimmack S, Taylor A, Lawrence B, Schmitz-Winnenthal H, Fischer L, B?chler MW, Modlin IM, Kidd M, Tang LH. Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling. Tumour Biol. 2015 Jan; 36(1):399-408.
    View in: PubMed
    Score: 0.102
  4. Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, Brink JA, Baker ME, Federle MP, Foley WD, Francis IR, Herts BR, Israel GM, Krinsky G, Platt JF, Shuman WP, Taylor AJ. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol. 2010 Oct; 7(10):754-73.
    View in: PubMed
    Score: 0.077
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support